Recro Pharma Inc reports results for the quarter ended in March - Earnings Summary

Societal CDMO

07/05/2021 21:59

* Recro Pharma Inc  REPH.OQ  reported a quarterly adjusted loss
of 23 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 25
cents per share.
* Revenue fell 22.8% to $16.80 million from a year ago​; 
analysts expected $16.43 million.
* Recro Pharma Inc's reported EPS for the quarter was a loss
of 23 cents​.
* The mean earnings estimate of analysts had fallen by
about 41.7% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate and  
* Recro Pharma Inc shares had fallen by 10.0% this quarter and
lost 11.9% so far this year.
* The company reported a quarterly loss of $6.76 million.
* Wall Street's median 12-month price target for Recro Pharma
Inc is $5.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 7 at 08:59 p.m. GMT. ​All
figures in US Dollars.​